PPSS expresses tumor markers such as transducin-like enhancer of split-1 (TLE1) and B-cell lymphoma 2 (Bcl-2), which can differentiate PPSS from other sarcomas, highlighting the importance of immunohistochemical (IHC) investigations as an important tool to rule out other sarcomas. Here, TLE1 is linked to neoplasm.